BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38173430)

  • 1. Association of
    Lai M; Qin YL; Jin QY; Chen WJ; Hu J
    World J Gastrointest Oncol; 2023 Dec; 15(12):2225-2236. PubMed ID: 38173430
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Wang P; Li Y; Li L; Zhong R; Shen N
    Front Oncol; 2021; 11():639438. PubMed ID: 34113561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between MBOAT7 rs641738 polymorphism and non-alcoholic fatty liver in overweight or obese children.
    Zusi C; Morandi A; Maguolo A; Corradi M; Costantini S; Mosca A; Crudele A; Mantovani A; Alisi A; Miraglia Del Giudice E; Targher G; Maffeis C
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1548-1555. PubMed ID: 33810963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of the association between MBOAT7 rs641738, TM6SF2 rs58542926 and nonalcoholic fatty liver disease susceptibility.
    Xia Y; Huang CX; Li GY; Chen KH; Han L; Tang L; Luo HQ; Bao MH
    Clin Res Hepatol Gastroenterol; 2019 Oct; 43(5):533-541. PubMed ID: 30824369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis.
    Xu Y; Li L; Xiang X; Wang H; Cai W; Xie J; Han Y; Bao S; Xie Q
    Gene; 2013 Sep; 527(2):584-93. PubMed ID: 23791656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals.
    Donati B; Dongiovanni P; Romeo S; Meroni M; McCain M; Miele L; Petta S; Maier S; Rosso C; De Luca L; Vanni E; Grimaudo S; Romagnoli R; Colli F; Ferri F; Mancina RM; Iruzubieta P; Craxi A; Fracanzani AL; Grieco A; Corradini SG; Aghemo A; Colombo M; Soardo G; Bugianesi E; Reeves H; Anstee QM; Fargion S; Valenti L
    Sci Rep; 2017 Jul; 7(1):4492. PubMed ID: 28674415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic predisposition in metabolic-dysfunction-associated fatty liver disease and cardiovascular outcomes-Systematic review.
    Ismaiel A; Dumitrascu DL
    Eur J Clin Invest; 2020 Oct; 50(10):e13331. PubMed ID: 32589269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association between miR-146a single nucleotide polymorphism and genetic susceptibility to hepatocellular carcinoma: a meta-analysis].
    Zhang LH; Zhang CY; Dai XZ; Zhang J; Zhang F
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):749-754. PubMed ID: 29108203
    [No Abstract]   [Full Text] [Related]  

  • 10. The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B.
    Thabet K; Chan HLY; Petta S; Mangia A; Berg T; Boonstra A; Brouwer WP; Abate ML; Wong VW; Nazmy M; Fischer J; Liddle C; George J; Eslam M
    Hepatology; 2017 Jun; 65(6):1840-1850. PubMed ID: 28109005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the association between five polymorphisms and risk of hepatocellular carcinoma: A meta-analysis.
    Yu JY; Hu F; Du W; Ma XL; Yuan K
    J Chin Med Assoc; 2017 Apr; 80(4):191-203. PubMed ID: 28188097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
    Mancina RM; Dongiovanni P; Petta S; Pingitore P; Meroni M; Rametta R; Borén J; Montalcini T; Pujia A; Wiklund O; Hindy G; Spagnuolo R; Motta BM; Pipitone RM; Craxì A; Fargion S; Nobili V; Käkelä P; Kärjä V; Männistö V; Pihlajamäki J; Reilly DF; Castro-Perez J; Kozlitina J; Valenti L; Romeo S
    Gastroenterology; 2016 May; 150(5):1219-1230.e6. PubMed ID: 26850495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children.
    Lin YC; Chang PF; Chang MH; Ni YH
    Liver Int; 2018 Jul; 38(7):1300-1307. PubMed ID: 29314568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease.
    Di Sessa A; Umano GR; Cirillo G; Del Prete A; Iacomino R; Marzuillo P; Del Giudice EM
    J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):69-74. PubMed ID: 29601441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
    Li JF; Zheng EQ; Xie M
    Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the association of a variant in PNPLA3 and TM6SF2 with fibrosis progression in patients with chronic hepatitis C infection after eradication: A retrospective study.
    Kang Q; Xu J; Luo H; Tan N; Chen H; Cheng R; Pan J; Han Y; Yang Y; Liu D; Xi H; Yu M; Xu X
    Gene; 2022 Apr; 820():146235. PubMed ID: 35143946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of GST genetic polymorphisms with the susceptibility to hepatocellular carcinoma (HCC) in Chinese population evaluated by an updated systematic meta-analysis.
    Liu K; Zhang L; Lin X; Chen L; Shi H; Magaye R; Zou B; Zhao J
    PLoS One; 2013; 8(2):e57043. PubMed ID: 23437305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis reveals an association between signal transducer and activator of transcription-4 polymorphism and hepatocellular carcinoma risk.
    Zhang L; Xu K; Liu C; Chen J
    Hepatol Res; 2017 Mar; 47(4):303-311. PubMed ID: 27126090
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Ismaiel A; Spinu M; Osan S; Leucuta DC; Popa SL; Chis BA; Farcas M; Popp RA; Olinic DM; Dumitrascu DL
    Med Pharm Rep; 2023 Jan; 96(1):41-51. PubMed ID: 36818318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Luo T; Chen J; Liu JJ; Li H; You XM; Wang HL; Zhu SL; Li LQ
    Onco Targets Ther; 2016; 9():4483-9. PubMed ID: 27499641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.